Article in ACS infectious diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed, 2 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
7 authors at 1 institution in 1 country.
John H MooreElectrical and Computer Engineering, University of Virginia, Charlottesville, Virginia 22904, United States.
Armita SalahiElectrical and Computer Engineering, University of Virginia, Charlottesville, Virginia 22904, United States.
Carlos HonradoElectrical and Computer Engineering, University of Virginia, Charlottesville, Virginia 22904, United States.
Christopher WarburtonElectrical and Computer Engineering, University of Virginia, Charlottesville, Virginia 22904, United States.
Steven TateElectrical and Computer Engineering, University of Virginia, Charlottesville, Virginia 22904, United States.
Cirle A WarrenInfectious Diseases, School of Medicine, University of Virginia, Charlottesville, Virginia 22903, United States.
Nathan S SwamiElectrical and Computer Engineering, University of Virginia, Charlottesville, Virginia 22904, United States.ORCID 0000-0002-0492-1160
University of Virginia · US
Funding
Alanyl-glutamine supplementation of standard treatment for C. difficile infectionR01AI145322 · NIAID · UNIVERSITY OF VIRGINIA · PI WARREN, CIRLE ALCANTARA · 2020 to 2024
$4.0M
Optimizing Inter-Microbial Antagonisms to Control Clostridium Difficile InfectionR21AI130902 · NIAID · UNIVERSITY OF VIRGINIA · PI SWAMI, NATHAN, WARREN, CIRLE ALCANTARA · 2017 to 2018
Antibiotic-induced microbiota disruption and its persistence create conditions for dysbiosis and colonization by opportunistic pathogens, such as those causing
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Correlating Antibiotic-Induced Dysbiosis to · full record | OpenQuestion